News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Nuvolase Inc. Release: PinPointe™ FootLaser™ Surpasses 100,000 Treatments for Onychomycosis



11/6/2012 9:08:15 AM

CHICO, Calif.--(BUSINESS WIRE)--NuvoLase Inc. announced today more then 100,000 procedures have now been performed with the PinPointe FootLaser worldwide, more than many of the other light-based options combined. The PinPointe FootLaser was the first light-based device to receive FDA clearance to treat onychomycosis (commonly known as nail fungus), and remains one of the only devices on the market today with documented clinically proven efficacy. The PinPointe FootLaser has been found to be an effective alternative to oral medications, which can be risky for the patient. The PinPointe FootLaser has been cleared by the FDA for the temporary improvement in the appearance of clear nail in patients with onychomycosis.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES